Atlas Trials

Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial

Clinical trial NCT06974370 · RECRUITING

Trial details

NCT number
NCT06974370
Sponsor
University of Vermont Medical Center
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Brain Metastases, AdultBrain Metastases From Non-small Cell Lung Cancer (NSCLC)
Start date
2025-06-05
Primary completion
2030-12-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.